Top related persons:
Top related locs:
Top related orgs:

Search resuls for: ". Department of Health"


25 mentions found


The emergency is also tied to telehealth flexibilities, Medicaid enrollment safeguards, and the ability of government health agencies to collect data on the spread of the coronavirus. Here is what will change after Thursday, and what does not:WILL THERE BE A COST FOR VACCINES, TESTS AND TREATMENTS? They will face co-pay or co-insurance costs for certain covered treatments and the full price of those that are not covered. People enrolled in state government Medicaid health plans for the poor will also get zero-cost vaccines. The U.S. Centers for Disease Control and Prevention (CDC) will have less authority to collect certain types of public health data after the emergency expires.
Governments were able to tailor their data reporting so it could be aggregated. Pulling the data closest to the outbreaks allowed us to publish nearly real-time information as the pandemic spread. Politicized rhetoric about vaccines also drove decisions in some parts of the country to end data reporting. As of this spring, only seven states continued to publish data on cases and deaths more than once a week. There is still much to do to fix the hodgepodge of antiquated, disconnected surveillance data systems that exist across governments.
Circuit Court of Appeals, the U.S. Justice Department said the order, from U.S. District Judge Reed O'Connor in Fort Worth, Texas, "has no legal justification and threatens the public health." It asked the court to stop the order from taking effect until it can fully hear the administration's appeal. He found that the federal task force that decides what preventive care must be covered under the federal healthcare law, also known as Obamacare, was unlawfully appointed, voiding all of that task force's determinations since 2010. More than 150 million people were eligible for preventive care free of charge as of 2020 under Obamacare, according to U.S. Department of Health and Human Services data. Reporting By Brendan Pierson in New York; Editing by Alexia Garamfalvi and Jonathan OatisOur Standards: The Thomson Reuters Trust Principles.
The proposal is aimed at protecting woman who live in states where abortion is illegal who travel out of state to have the procedure done - something thousands of women are already doing, research shows. It is unclear whether the proposed rule would actually stifle criminal investigations. The federal Employee Retirement Income Security Act of 1974 (ERISA) covers most health insurance and other company benefit plans and generally preempts state laws on abortion-related coverage. But it does not prevent states from prosecuting plans, sponsors, administrators and their employees in all instances. Reporting By Jarrett Renshaw and Heather Timmons; Editing by Heather Timmons and Mark PorterOur Standards: The Thomson Reuters Trust Principles.
The Biden administration on Wednesday will propose new health privacy protections to prevent protected health information from being used to investigate or sue people who facilitate abortions, senior administration officials said. Vice President Kamala Harris will announce the new language, aimed at strengthening existing privacy rule protections under the Health Insurance Portability and Accountability Act of 1996, when she meets with a task force on access to reproductive health care Wednesday afternoon. The HHS proposal centers on barring using or disclosing protected health information that could be used to identify, investigate, prosecute or sue people, health care providers and others involved in seeking or providing abortion care. In a document outlining its proposal, the White House said taking steps to protect sensitive health information had taken on "renewed importance" in light of such efforts. The proposed rule would continue to allow a regulated entity such as a health insurance company or provider to use or disclose protected health information "for permissible purposes" under the privacy rule, a senior administration official said.
April 7 (Reuters) - The federal judge who on Friday suspended approval of the abortion pill mifepristone is a former Christian legal activist whose small courthouse in Amarillo, Texas, has become a go-to destination for conservatives challenging Biden administration policies. U.S. District Judge Matthew Kacsmaryk, an appointee of former Republican President Donald Trump, had a long track record of opposing abortion and LGBTQ rights before the U.S. Senate confirmed him in 2019 to a life-tenured position as a federal judge. FAVORED VENUESince then, his courthouse has become a favored venue for conservative legal activists and Republican state attorneys general pursuing lawsuits seeking to halt aspects of Democratic President Joe Biden's agenda - often with success. In October, Kacsmaryk vacated Biden administration guidance requiring employers to allow transgender workers to dress and use bathrooms consistent with their gender identities. Reporting by Nate Raymond in Boston, Editing by Alexia Garamfalvi, Bill Berkrot and Diane CraftOur Standards: The Thomson Reuters Trust Principles.
Pool via REUTERSApril 8 (Reuters) - The federal judge who on Friday suspended approval of the abortion pill mifepristone is a former Christian legal activist whose small courthouse in Amarillo, Texas, has become a go-to destination for conservatives challenging Biden administration policies. U.S. District Judge Matthew Kacsmaryk, an appointee of former Republican President Donald Trump, had a long track record of opposing abortion and LGBTQ rights before the U.S. Senate confirmed him in 2019 to a life-tenured position as a federal judge. When anti-abortion groups in November filed a lawsuit challenging the U.S. Food and Drug Administration's more than two-decade old approval of the abortion pill mifepristone, they filed in Amarillo, guaranteeing the case would be heard by Kacsmaryk. FAVORED VENUESince then, his courthouse has become a favored venue for conservative legal activists and Republican state attorneys general pursuing lawsuits seeking to halt aspects of Democratic President Joe Biden's agenda - often with success. While the district's chief judge could order cases be reallocated, he has not.
March 30 (Reuters) - A federal judge in Texas on Thursday blocked Obamacare's mandate that health insurance plans cover pre-exposure prophylaxis against HIV (PrEP) and other preventive care including cancer and diabetes screenings. U.S. District Judge Reed O'Connor in Fort Worth, Texas, said the PrEP mandate violated a federal religious freedom law and that the other preventive care mandates were based on recommendations by an illegally appointed task force. The ruling was a victory for conservative businesses and individuals that sued to challenge the mandates in 2020. The U.S. Department of Health and Human Services, which oversees Obamacare, did not immediately respond to a request for comment. Reporting By Brendan Pierson in New York; Editing by Mark PorterOur Standards: The Thomson Reuters Trust Principles.
US declines to force lower price on cancer drug Xtandi
  + stars: | 2023-03-21 | by ( ) www.reuters.com   time to read: +2 min
WASHINGTON, March 21 (Reuters) - The U.S. government will not force Pfizer Inc (PFE.N) and Astellas Pharma Inc (4503.T) to lower the price of their prostate cancer drug Xtandi using its emergency "march-in" authority, the National Institutes of Health (NIH) said on Tuesday. Patient group the Union for Affordable Cancer Treatment first filed a petition calling on the NIH to use its authority to lower the drug's price in March 2016. The NIH said in a letter made public on Tuesday that its analyses in response to the petition found the prostate cancer treatment was widely available. "NIH does not believe that use of the march-in authority would be an effective means of lowering the price of the drug," the letter said. Progressive lawmakers in the Democratic Party have been calling on President Joe Biden's administration to use its march-in authority to lower drug prices.
The Alzheimer's Association and the pharmaceutical industry say the drug companies are not directly involved in the campaign. But the Alzheimer's Association says patients simply don't have the time to spare. The agency did not address the Alzheimer's Association campaign. Association members have met 30 times with staffers for the state's 20 members of Congress, Ryan Schiff, the chapter's public policy manager, said. Spokespeople for all three companies said they do not work with the Association on its campaign to expand Medicare coverage of the drugs.
New mandate requires most office workers to come into the office at least 3 times a week starting in May. About 3 weeks since the announcement of the new policy, more than 29,200 Amazon employees have signed an internal petition opposing the mandate. Roughly 30,000 Amazon employees have joined that Slack channel, which was created shortly after the RTO announcement. In the petition, Amazon employees added internal data supporting continued remote work and dozens of comments explaining why they oppose the change. A 2013 Stanford University study of Chinese workers found that remote workers are 13% more productive than their in-office counterparts.
The posts read, “DID YOU KNOW: Blue Cross Blue Shield pays pediatricians a $40,000 bonus for fully vaccinating 100 patients under the age of 2. The full document does describe an incentive program offered to Michigan providers in 2016, and the excerpt seen in the posts about childhood vaccines is on the document’s page 15. “While vaccinations may fall into that category, they would not be the sole performance measure,” said a spokesperson for the Blue Cross Blue Shield Association (BCBSA), which represents the insurer’s affiliates in multiple states. Each of the 34 Blue Cross and Blue Shield companies “sets its own value-based contracts and determines which performance measures would be taken into account for incentives,” she added. A 2016 Michigan program paid individual providers smaller maximum amounts for vaccinating children than claimed online.
A deeper look at the company's billing practices revealed what appeared to be Medicare fraud, Pérez Aybar said. Fraud flourishesThat's just one of thousands of examples of how Medicare fraud is flourishing — not only in south Florida, but across the country. Taxpayers are losing more than $100 billion a year to Medicare and Medicaid fraud, according to estimates from the National Health Care Anti-Fraud Association. This convicted felon says Medicare and Medicaid fraud is "very easy" to get away with. The same pills could be sold and resold multiple times with different phony patients, billing Medicare each time.
[1/2] People pose with syringe with needle in front of displayed Moderna logo in this illustration taken, December 11, 2021. REUTERS/Dado Ruvic/IllustrationFeb 15 (Reuters) - The U.S. government should face a patent lawsuit over COVID-19 vaccines, not vaccine maker Moderna Inc (MRNA.O), the Department of Justice told a Delaware federal court on Tuesday. Moderna made the same argument last year in an unsuccessful bid to win an early dismissal of the lawsuit. Both Moderna and Pfizer Inc (PFE.N) have been the target of multiple patent lawsuits over their COVID vaccines, including a lawsuit brought by Moderna against Pfizer in August. The case is Arbutus Biopharma Corp v. Moderna Inc, U.S. District Court for the District of Delaware, No.
WASHINGTON, Feb 7 (Reuters) - Texas sued the administration of U.S. President Joe Biden on Tuesday to prevent it from asking pharmacies to fill reproductive health prescriptions. The Biden administration said in July 2022 that refusing to fill prescriptions for drugs that could be used to terminate a pregnancy could violate federal law, regardless of various state bans on the procedure. The lawsuit was filed on Tuesday against the U.S. Department of Health and Human Services in the U.S. District Court for the Western District of Texas. The Food and Drug Administration said January that abortion pills would become more widely available at pharmacies and through the mail. A legal battle is under way at a federal court in Texas, where abortion opponents have sued to undo the approval of the drugs.
Every weekday the CNBC Investing Club with Jim Cramer holds a "Morning Meeting" livestream at 10:20 a.m. Opportunity to buy Caterpillar Confident in decision to buy Johnson & Johnson Why buy ahead of an overhang? Opportunity to buy Caterpillar Shares of Caterpillar (CAT) were down 4.2% mid-morning Tuesday after the company reported earnings before the bell. Why we bought more Johnson & Johnson Shares of Johnson & Johnson (JNJ) fell Tuesday after a U.S. appeals court on Monday dismissed the pharmaceutical giant's bankruptcy strategy for tens of thousands of lawsuits concerning the company's talc products. As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade.
Jan 30 (Reuters) - Drug manufacturers can limit healthcare providers' use of outside pharmacies for dispensing drugs under a federal drug discount program, a federal appeals court ruled Monday. The case centers on the federal 340B program, in which drugmakers provide discounts to eligible healthcare providers that serve low-income populations. Drugmakers are required to participate in the 340B program in order to receive funds from government health insurance programs like Medicare and Medicaid. Sanofi, Novo Nordisk and AstraZeneca all continued to allow 340B providers without in-house pharmacies to use a single contract pharmacy. HHS ordered them to stop, saying the new policies were not allowed under the 340B program.
A sign on an insurance store advertises Obamacare in San Ysidro, San Diego, California, U.S., October 26, 2017. REUTERS/Mike Blake(Reuters) - The U.S. government on Monday proposed a new rule to expand coverage of the Obamacare health insurance plans for all women who need or want birth control. Regulations in 2018 expanded exemptions for religious beliefs and moral convictions allowing private health plans and insurers to exclude coverage of contraceptive services. The new rules proposed by the U.S. Department of Health & Human Services (HHS) and the Departments of Labor and the Treasury would remove the moral exemption and retain the existing religious exemption. The rules would ensure that “tens of millions of women across the country” who have access to birth control coverage under the Affordable Care Act would get access to contraception, the HHS said.
A sign on an insurance store advertises Obamacare in San Ysidro, San Diego, California, U.S., October 26, 2017. REUTERS/Mike BlakeWASHINGTON (Reuters) -Women whose employers have opted out of covering contraceptives under their health insurance plans on religious grounds would gain no-cost access to birth control under a rule proposed by the Biden administration on Monday. The Affordable Care Act (ACA), also known as Obamacare, requires private insurance plans to cover recommended preventive services including contraception without any patient cost-sharing, but current regulations grant exemptions for religious or moral objections. If the new rule is implemented, women enrolled in plans governed by the ACA would gain birth control coverage regardless of employer exemption, the U.S. Department of Health and Human Services (HHS) said in a statement. The rule would also remove employer moral objections as grounds for exemption from coverage but keep religious ones in place.
Long Covid is keeping people out of work and may reduce on-the-job productivity for others, contributing to a labor shortage and weighing on the U.S. economy at large, according to a new study. Long Covid — also known as long-haul Covid, post-Covid or post-acute Covid syndrome — is a chronic illness that results from a Covid-19 infection. Up to 30% of Americans develop long Covid after a Covid infection, affecting as many as 23 million Americans, the U.S. Department of Health and Human Services said in November. About 18% of people with long Covid hadn't returned to work for more than a year after contracting Covid, according to a recent study by the New York State Insurance Fund, the state's largest workers' compensation insurer. The labor force participation rate was 62.3% in December, which has shown "little net change" since early 2022 and remains a percentage point below its pre-pandemic level, according to the Bureau of Labor Statistics most recent jobs report.
Nearly 16 million Americans sign up for 2023 Obamacare plans
  + stars: | 2023-01-11 | by ( ) www.reuters.com   time to read: +1 min
[1/2] U.S. President-elect Joe Biden adjusts his face mask after during a news conference, where he discussed health care and the Affordable Care Act (Obamacare, at the theater serving as his transition headquarters in Wilmington, Delaware, U.S., November 10, 2020. REUTERS/Jonathan ErnstJan 11 (Reuters) - Nearly 16 million Americans have so far signed up for health insurance through the Affordable Care Act's marketplace, a 13% jump from a year earlier, according to the U.S. Department of Health and Human Services (HHS) on Wednesday. Enrollment for 2023 healthcare plans under the Affordable Care Act, also known as Obamacare, is open between Nov. 1 and Jan. 15. About 3.1 million people who have signed up for the plans are new enrollees, HHS said. Obamacare helps low and middle-income Americans who do not have access to affordable health insurance coverage through an employer.
Social Security disability benefits are generally available to workers who have earned enough credits through payroll taxes — typically 40 credits, though younger workers may qualify with less. Supplemental Security Income, or SSI, is a federal benefit available to disabled individuals who may not qualify for Social Security disability based on their work records. Allsup, which works with NASA, helped Perry get his Social Security disability benefits application approved. "That can really make or break a Social Security disability case," he said. Social Security disability benefits are aimed at long-term conditions.
The law targets fraud and abuse, such as bribery, in federal healthcare programs including Medicare, which provides coverage for the elderly and disabled. Pfizer contends the government's interpretation of the law was blocking access to critical medical care. New York-based Pfizer's medication, also known as tafamidis, treats a rare heart condition known as transthyretin amyloid cardiomyopathy that can lead to progressive heart failure. Given the drug's high price, patients would need to bear yearly co-payments of roughly $13,000, with Medicare covering the rest. Pfizer's proposal sought to assist "middle-income" patients who do not qualify for low-income co-pay support but might still be deterred by its cost.
A shocking headline recently claimed that every year 250,000 people in the U.S. die after misdiagnosis in the emergency room. Even more shocking, the statistic was extrapolated from the death of one man—in a Canadian emergency room more than a decade ago. The figure comes from a Dec. 15 report by the Agency for Health Care Research and Quality. The AHRQ, part of the U.S. Department of Health and Human Services, produces research to improve healthcare in America.
Psychedelic therapy is nowhere near as simple as filling a prescription and taking a pill at home. A clinical psychologist, she founded and now leads the first accredited psychedelic therapy training program in the U.S. at the California Institute of Integral Studies. The psychedelic therapy program entails 150 hours of instruction and several in-person training sessions. So why the growing interest in using psychedelic drugs for mental health? Treatment with psychedelic drugs is not as simple as giving the patient a pill to take at home, and it’s not for everybody.
Total: 25